After Hours
$
1.76
Change
+0.04 +2.33%
Volume
Volume 1,042
Jun 2, 2023, 7:56 p.m.
Quotes are delayed by 20 min
Previous close
$ 1.66
$ 1.72
Change
+0.06 +3.61%
Day low
Day high
$1.64
$1.72

52 week low
52 week high
$0.80
$2.28

Market cap
$108.69M
Average volume
222,607
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-0.31
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ONCY
-
Oncolytics Biotech started at buy with $3 stock price target at Maxim Group
- Tomi Kilgore
-
On the Road to Riches in Biotech
- Barron's Online
-
Oncolytics prices offering at 14% discount
- MarketWatch.com
-
Canada hot stocks : Oncolytics, Just Energy
- MarketWatch.com
-
Oncolytics shares up on positive Reolysin results
- MarketWatch.com
-
Oncolytics rises 27% after positive Phase III data
- Steve Gelsi
-
Oncolytics Biotech up 27% in premarket
- Steve Gelsi
-
Wednesday’s biggest gaining and declining stocks
- MarketWatch
-
Six Picks for Health-Care Portfolios
- Barron's Online
-
Tuesday's biggest stock gainers and decliners
- MarketWatch
-
Tuesday's biggest stock gainers and decliners
- Michael Baron
-
Oncolytics shares rise on data from Reolysin study
- Gabriel Madway
-
Oncolytics Biotech up 13% at $2.20
- Tomi Kilgore
-
Tuesday's biggest stock gainers and decliners
- Michael Baron
-
Wednesday's biggest U.S. stock gainers and decliners
- MarketWatch
-
Oncolytics Biotech gets U.K. approval for Reolysin trial
- Gabriel Madway
-
Oncolytics Biotech gets U.K. approval for Reolysin trial
- Gabriel Madway
-
Oncolytics Biotech shares up 4.3% at $2.18
- Gabriel Madway
-
Friday's biggest stock gainers and decliners
- MarketWatch
- Loading more headlines...
Analyst Ratings
Other News on ONCY
-
2 Sector ETFs Hovering Around a 52-Week High
- Zacks.com
-
Oncolytics Biotech, Inc. (ONCY) Q3 2022 Earnings Call Transcript
- Seeking Alpha
Press Releases on ONCY
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com